LIAISON® DHEA-S. - COFEPRIS Registration 2566R2018 SSA
Access comprehensive regulatory information for LIAISON® DHEA-S. (LIAISON® DHEA-S.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2566R2018 SSA and manufactured by DIASORIN MÉXICO, S.A. DE C.V.. The device was registered on November 07, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO LIAISON® DHEA-S EMPLEA LA TECNOLOGÍA DE LA QUIMIOLUMINISCENCIA (CLIA) EN UN ENSAYO INMUNOLÓGICO PARA LA DETERMINACIÓN CUANTITATIVA IN VITRO DEL SULFATO DE DEHIDROEPIANDROSTERONA EN MUESTRAS DE SUERO O DE PLASMA HUMANO. EL ENSAYO DEBE REALIZAR
THE LIAISON® DHEA-S ASSAY EMPLOYS CHEMILUMINESCENCE TECHNOLOGY (CLIA) IN AN IMMUNOLOGICAL ASSAY FOR THE IN VITRO QUANTITATIVE DETERMINATION OF DEHYDROEPIANDROSTERONE SULFATE IN HUMAN SERUM OR PLASMA SAMPLES. THE TEST MUST PERFORM